Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present InterCare DX, Inc. (OTC: ICCO).

Full DD Report for ICCO

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-10N/A0.01N/AN/A0
2018-12-07N/A0.01N/AN/A0
2018-12-06N/A0.01N/AN/A0
2018-12-05N/A0.01N/AN/A0
2018-12-04N/A0.01N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-04-249,00620,00045.0300Short
2018-02-2210,00010,000100.0000Short
2016-01-1250,00050,000100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ICCO.


About InterCare DX, Inc. (OTC: ICCO)

Logo for InterCare DX, Inc. (OTC: ICCO)

InterCare Dx, Inc., is a USFDA registered biomedical and life sciences company with main office located at South Vermont Avenue, Suite , Torrance, California, USA, and international partners located worldwide..We have also developed an Integrated, web enabled applications target towards a Education Management, b Hospitality Management, c Legal System Management, d Human Capital Management and e Healthcare Management industry markets. In addition, we designed, developed and commercialized the The Mirage Systems Biofeedback and Self Regulation Software Program , the first USFDA approved Software only biofeedback program for clinical use. This product was licensed to United States Navy Submarine division in San Diego California in and a research center in Germany We have also Commercialized Vascular Diagnostic Center Vasocor Model , a freestanding diagnostic device that employs a revolutionary non invasive, inexpensive, easy to use procedure that has been clinically proven to detect coronary artery disease CAD earlier and more accurately than existing techniques. Users include primary care physicians, cardiologists, vascular specialists, clinics, and hospitals. The device is simple enough to be operated by non physicians and non nurses. Further, the Vasocor device has FDA approval, validated clinical trial data and qualified for Medicare reimbursement.

 

Contact Information

 

 

Current Management

  • Anthony C Dike / Founder
  • Anthony C Dike / Executive Chairman

Current Share Structure

  • Market Cap: $668,735 - 03/19/2018
  • Authorized: 100,000,000 - 03/19/2018
  • Issue and Outstanding: 74,303,902 - 03/19/2018
  • Float: 2,000,000 - 11/07/2007

 



Daily Technical Chart for (OTC: ICCO)

Daily Technical Chart for (OTC: ICCO)


Stay tuned for daily updates and more on (OTC: ICCO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ICCO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ICCO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ICCO and does not buy, sell, or trade any shares of ICCO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/